Milestones of cardiovascular therapy. III. Nitroglycerin;Milníky kardiovaskulární terapie III. Nitroglycerin

Casopis Lekaru Ceskych

Volumn 146, Issue 6, 2007, Pages 533-537

  Jerie, P ^a  

^a Reinach/BL 1 ^*  (Switzerland)

Author keywords

Amyl nitrite; Dinitrate; Glyceroltrinitrate; Isosorbide; Isosorbide 5 mononitrate; Nitrates; Nitrites; Nitroglycerin; Sodium nitroprusside; Tolerance

Indexed keywords

GLYCERYL TRINITRATE; VASODILATOR AGENT;

ARTICLE; HUMAN;

HUMANS; NITROGLYCERIN; VASODILATOR AGENTS;

EID: 34347261732     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Snellen, H. A.: History of cardiology. Rotterdam, Donker Academic Publications, 1984, s. 191.
2. White, P. D.: Heart disease. New York, The Macmillan Comp., 1964, s. 1025.
3. Martindale: The complete drug reference. Sweetman S. C. (ed.). London, Chicago, Pharmaceutical Press, 2005, s. 2576.
4. Gilman, A. G., Goldman, L. S. (eds.): The Pharmacological Basis of Therapeutics, 7th edition, New York Macmillan, 1985, s. 1839.
5. Osler, W.: The Principles and Practice of Medicine. New York, London, D. Appleton, 1892, s. 645.
6. Osier, W.: The Principles and Practice of Medicine. 12th edition, revision by Th. McCrae, New York, London, D. Appleton-Century Comp., 1935, s. 713.
7. Goldberg, L.: Pharmacological properties of sorbide dinitrate. Acta Physiol. Scand., 1948, 15, s. 173-178.
8. Krantz, J. C. Jr., Carr, C. J., Forman, S. E. et al.: Mechanism and action of organic nitrates. J. Pharmacol. Exp. Therap., 1940, 70, s. 323-327.
9. Braunwald, E., Maroko, P. R.: Evidence to support the hypothesis that myocardial size can be limited following coronary occllusion. In: Rapaport, E.(ed.). Current controversies in cardiovascular disease. Philadelphia, London, Toronto, W. B. Sanders, 1980, s. 295-310.
10. Needleman, P.: Efficacy of long acting nitrates. Amer. J. Cardiol., 1976, 38, s. 400-401.
11. Krantz, J. J. Jr.: Efficacy of long acting nitrates. Reply. Amer. J. Cardiol., 1976, 38, s. 401-402.
12. Jerie, P.: Efficacy of long acting nitrates. II. Peroral Isosorbide dinitrate. Amer. J. Cardiol., 1976, 38, s. 402.
13. Hamsík, A.: Lékařská chenue. Díl III. Organická chemie. Praha, Dr. Ed. Grégr a syn, 1939, s. 295.
14. Vítovec, J., Špinar, J.: Farmakoterapie kardiovaskulárních onemocnění. Praha, Grada, 2000, s. 249.
15. Cohen, M., Kirk, E. S.: Differential response of large and small coronary arteries to nitroglycerin and angiotensin: autoregulation and tachyphylaxis. Circ. Res., 1973, 33, s. 445-453.
16. Sosin, M. D., Bhatia, G., Lip, G. Y. H, Davies, M. K.: Heart failure. Investigation, Diagnosis, Treatment. London, Manson Publ., 2006, s. 144.
17. Ganz, W., Marcus, H. S.: Failure of intracoronary nitroglycerin to alleviate pacing-induced angina. Circulation, 1972, 406, s. 880-889.
18. Parker, J. D.: Nitrate tolerance, oxidation stress, and mitochondrial function: and other worrisome chapter on the effects of organic nitrates. J. Clin. Invest., 2004, 113, s. 352-354.
19. Cohn, J. N., Johnson, G., Ziesche, S. et al.: A comparison of enalapril with hydralazin-isosorbide dinitrate in the treatment of chronic congestive heart failure. N. Engl. J. Med., 1991, 325, s. 303-310.
20. Safar, M. E., O'Rourke, M. F.(eds.): Arterial stiffness in hypertension. Edinburgh, Elsevier, 2006, s. 598+XIX.
21. Dollery, C. T., Frishman, W. H., Cruickshank, J. M.: Current cardiovascular drugs. London, Current Science, Ltd., 1993, s. 271.
22. Anand, I. S., Tam, W., Rector, T. S. et al.: Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart failure trial. J. Am. Coll. Cardiol., 2007, 49, s. 32-39.